Branded

Press enter to search
Close search
Open Menu

Branded

News and information on branded drugs sold in retail pharmacies, as well as their suppliers.

A case of injectables.

Cumberland gets FDA nod for RediTrex

Cumberland's RediTrex injection is a treatment for adult and pediatric patients with rheumatoid arthritis, as well as adults with psoriasis.

An illustration of an envelope with a paper that has a check mark.

FDA approves Zai Lab partner, GSK’s expanded indication for Zejula

Zejula is now the only, once-daily PARP inhibitor approved as monotherapy treatment for recurrent ovarian cancer beyond those with a BRCA mutation in both the recurrent maintenance and late-line treatment settings.

A man holding an FDA approved sign.

The FDA has approved a new antibacterial drug to treat complicated UTIs.

Arakoda, the first antimalarial product approved by the Food and Drug Administration for the prevention of malaria, is being made available at select pharmacies and wholesalers.

An illustration of an envelope with a paper that has a check mark.

Novartis’ Adakveo is the first targeted therapy to treat patients with a painful complication of sickle cell disease.

An illustration of an envelope with a paper that has a check mark.

As part of an international collaboration, the FDA has approved AstraZeneca's new treatment option for patients with chronic lymphocytic leukemia.

An illustration of an envelope with a paper that has a check mark.

The FDA has approved Xcopri, a new treatment for adults with partial-onset seizures.

Upsher-Smith has added Zembrace SymTouch injection to its savings program for patients

The words approved in caps and red letters.

BeiGene USA's Brukinsa provides a treatment for patients with relapsed and refractory mantle cell lymphoma

A man holding an FDA approved sign.

Alnylam’s Givlaari has been approved by the FDA to treat a genetic disorder the causes buildup of toxic porphyrin molecules, which are formed during the production of heme.

A syringe with a vial.

Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains.

An illustration of an envelope with a paper that has a check mark.

RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy.

prep

SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

Celgene’s Reblozyl is the first therapy to treat patients with a rare blood disorder.

Show More